Zai Lab Ltd ( (HK:9688) ) has issued an announcement.

Zai Lab Limited has granted new share options and restricted share units under its 2024 Equity Incentive Plan, issuing options over 20,000 shares to one employee and RSUs over 848,930 shares to four grantees, including Chairperson and CEO Dr. Samantha Du. The awards, which vest over multiple years and carry no performance targets or clawback mechanisms, underscore the company’s reliance on long-term equity incentives to align management and staff with shareholder interests and support retention of key personnel.

The stock options are priced at US$19.12 per ADS with a ten-year term, vesting in four equal annual tranches contingent on continued employment, while the RSUs are granted at no purchase price and similarly structured to promote long-term commitment. By confirming that these terms are consistent with market practice and its established policies, Zai Lab signals a continued emphasis on competitive remuneration, which may influence its cost structure but is intended to strengthen leadership stability and support execution of its growth strategy.

The most recent analyst rating on (HK:9688) stock is a Hold
with a HK$18.00 price target.
To see the full list of analyst forecasts on Zai Lab Ltd stock,
see the HK:9688 Stock Forecast page.